COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 230: Articles 2291-2300  | Next

Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Das Jana, I., Kanjo, K., Roy, S., Bhasin, M., Bhattacharya, S., Banerjee, I., Jana, S., Chatterjee, A., Chakraborty, A., Chakraborty, S., Mukherjee, B., Varadarajan, R., Mondal, A.
10.1101/2024.07.08.602485 — Posted: 2024-07-08
Structural impact of synonymous mutations in six SARS-CoV-2 Variants of Concern
Ziesel, A., Jabbari, H.
10.1101/2024.07.06.602340 — Posted: 2024-07-08
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR Network Study
Nunes, B., Humphreys, J., Nicolay, N., Braeye, T., Van Evercooren, I., Hansen, C. H., Moustsen-Helms, I. R., Sacco, C., Fabiani, M. R., Castilla, J., Martinez-Baz, I., Meijerink, H., Machado, A., Soares, P., Ljung, R., Pihlstrom, N., Nardone, A., Bacci, S., Monge, S., VEBIS-EHR working group
10.1101/2024.07.04.24309832 — Posted: 2024-07-07
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
Haddad, N. S., Morrison-Porter, A., Quehl, H., Capric, V., Lamothe, P. A., Anam, F., Runnstrom, M. C., Truong, A. D., Dixit, A. N., Woodruff, M. C., Chen, A., Park, J., Nguyen, D. C., Hentenaar, I., Kim, C. Y., Kyu, S., Stewart, B., Wagman, E., Geoffroy, H., Sanz, D., Cashman, K. S., Ramonell, R. P., Cabrera-Mora, M., Alter, D. N., Roback, J. D., Horwath, M. C., O'Keefe, J. B., Dretler, A. W., Gripaldo, R., Yeligar, S. M., Natoli, T., Betin, V., Patel, R., Vela, K., Hernandez, M. R., Usman, S., Varghese, J., Jalal, A., Lee, S., Le, S. N., Amoss, R. T., Daiss, J. L., Sanz, I., Lee, F. E.-H.
10.1101/2024.07.05.24310017 — Posted: 2024-07-07
A qualitative study exploring Emergency Department Staff attitudes to COVID-19 research
Quinn, J., Ho, A., Blunsum, A., Lowe, D. J.
10.1101/2024.07.04.24309781 — Posted: 2024-07-07
Comparison of excess deaths and laboratory-confirmed COVID-19 deaths during a large Omicron epidemic in 2022 in Hong Kong
Xin, H., Law, A., Cheung, J., Lin, Y., Wu, P., Li, Z., Cowling, B. J., Yang, W., Wong, J.
10.1101/2024.07.04.24309940 — Posted: 2024-07-07
Publication trend, impact and performance in mental health during and post COVID-19 pandemic
Bahar, N., Nor Rashid, F. A., Ahmad, N. D.
10.1101/2024.07.04.24309983 — Posted: 2024-07-07
From a single sequence to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2 protein sequences
Lamb, K. D., Hughes, J., Lytras, S., Koci, O., Young, F., Grove, J., Yuan, K., Robertson, D. L.
10.1101/2024.07.05.602129 — Posted: 2024-07-06
Relationship between acute SARS-CoV-2 viral clearance with Long COVID Symptoms: a cohort study
Herbert, C. B., Antar, A. A., Broach, J., Wright, C., Stamegna, P., Luzuriaga, K., Hafer, N., McManus, D. D., Manabe, Y. C., Soni, A.
10.1101/2024.07.04.24309953 — Posted: 2024-07-05
Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach
Phillips, D. J., Christodoulou, M. D., Feng, S., Pollard, A. J., Voysey, M., Steinsaltz, D.
10.1101/2024.07.02.24309776 — Posted: 2024-07-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).